Pharmaceutical Product Development, Inc.
(NASDAQ:PPDI)|
25.24 -1.10 (-4.18%) 1:23ET Delayed |
|
|
|
- Compare PPDI with:
- View: Line | Candlestick
Company Profile
Pharmaceutical Product Development, Inc.
929 North Front Street
Wilmington, -2 28401
United States - Map
Phone: (910) 251-0081
Fax: (910) 762-5820
Website: www.ppdi.com
State of incorporation: North Carolina
CEO: Dr. Fredric N. Eshelman, Pharm.D.
Employees: 10,200
Sector: Healthcare
Industry Group: Health Services
Industry: Medical Laboratories & Research
Contract research organization
The Company is a global contract research organization providing drug discovery and development services, post-approval expertise and compound partnering programs.
Recent news for PPDI
-
PPD boosts quarterly dividend by 25 percent
AP - Nov 14 at 4:01 ET
-
PPD Declares Fourth Quarter Dividend
Business Wire - Nov 11 at 4:10 ET
-
PHARMACEUTICAL PRODUCT DEVELOPMENT INC Financials
EDGAR Online Financials - Nov 08 at 9:04 ET
-
TSC Ratings' Updates: Whole Foods
TheStreet.com - Nov 06 at 5:39 ET
-
PHARMACEUTICAL PRODUCT DEVELOPMENT INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 05 at 9:41 ET
-
Contract Research Stocks Hit by Growth Worries
SmartMoney.com - Nov 04 at 2:33 ET
-
Drug Industry Vets Back Group Behind Controversial Obama Ad
The Wall Street Journal Online - Nov 03 at 10:41 ET
-
PPD Chairman of the Board Pledges $5 Million to Rutgers' Ernest Mario School of Pharmacy
Business Wire - Oct 29 at 3:24 ET
-
PPD meets 3Q earnings estimates but lowers full-year forecast
bizjournals.com - Oct 22 at 9:45 ET
-
PR Newswire - Oct 22 at 8:20 ET
Top members owning PPDI
-
Top 39%
-26.60%3m:
-26.60%YTD:
-
Top 51%
-33.77%3m:
-33.77%YTD:
-
Top 76%
-45.86%3m:
-45.86%YTD: